Fibersol-2 Clinical Trials Related to Appetite
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01305291 |
Recruitment Status :
Completed
First Posted : February 28, 2011
Last Update Posted : February 28, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Lack of Satiety | Other: placebo Dietary Supplement: digestion-resistant maltodextrin | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Basic Science |
Official Title: | Fibersol-2 Clinical Trials Related to Appetite |
Study Start Date : | November 2008 |
Actual Primary Completion Date : | July 2009 |
Actual Study Completion Date : | November 2009 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: tea only without fibersol-2
|
Other: placebo |
Active Comparator: tea only with fibersol-2 (10 g)
|
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2 |
Placebo Comparator: tea without fibersol-2 and meal
|
Other: placebo |
Experimental: tea with 5 g fibersol-2 and meal
|
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2 |
Experimental: tea with 10 g fibersol-2 and meal
|
Dietary Supplement: digestion-resistant maltodextrin
Other Name: Fibersol-2 |
- Visual analog scale questionnaire subjective satiety responses [ Time Frame: 4 hours ]Hunger survey (30 minutes before meal and every half hour for 4 hours postprandial) (analogue scores)
- serum cholecystokinin (CCK) [ Time Frame: 4 hours ]0, 30, 60, 120, 180, and 240 min post-meal
- serum peptide YY (PYY) [ Time Frame: 4 hours ]0, 30, 60, 120, 180, and 240 min post-meal
- serum glucagon-like peptide-1 (GLP-1) [ Time Frame: 4 hours ]0, 30, 60, 120, 180, and 240 min post-meal
- serum ghrelin [ Time Frame: 4 hours ]0, 30, 60, 120, 180, and 240 min post-meal
- serum gastric inhibitory peptide (GIP) [ Time Frame: 4 hours ]0, 30, 60, 120, 180, and 240 min post-meal
- serum total cholesterol [ Time Frame: 4 hours ]0, 30, 60, 120, 180, 240 min
- serum LDL-cholesterol [ Time Frame: 4 hours ]0, 30, 60, 120, 180, 240 min
- serum HDL-cholesterol [ Time Frame: 4 hours ]0, 30, 60, 120, 180, 240 min
- serum triglycerides [ Time Frame: 4 hours ]0, 30, 60, 120, 180, 240 min
- serum free fatty acids [ Time Frame: 4 hours ]0, 30, 60, 120, 180, 240 min
- serum glucose [ Time Frame: 2 hours ]0, 30, 60, 90, 120 min
- serum insulin [ Time Frame: 2 hours ]0, 30, 60, 90, 120 min
- gastrointestinal symptoms questionnaire [ Time Frame: 24 h ]subjects recorded incidents and severity of gastrointestinal symptoms post treatment over 24 h
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 62 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
i. No known food allergies
ii. Normal healthy individuals
iii. No food intake abnormalities or abnormal feeding behaviors
iv. Average American BMI (21-28)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01305291
United States, Iowa | |
Nutrition and Wellness Research Center | |
Ames, Iowa, United States, 50011 |
Principal Investigator: | Suzanne Hendrich, PhD | Iowa State University |
Responsible Party: | Suzanne Hendrich, Iowa State University |
ClinicalTrials.gov Identifier: | NCT01305291 |
Other Study ID Numbers: |
ADM FB2-1 Hendrich 08-291 ( Other Identifier: ISU IRB ) |
First Posted: | February 28, 2011 Key Record Dates |
Last Update Posted: | February 28, 2011 |
Last Verified: | February 2011 |
dietary fiber satiety response hunger CCK |
PYY ghrelin GIP GLP-1 |